Literature DB >> 216448

N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver.

M Aggerbeck, G Guellaën, J Hanoune.   

Abstract

1 The alpha-adrenoceptor of rat liver plasma membranes was studied by use of the specific alpha-antagonist [3H]-dihydroergocryptine ([3H]-DHEC). Catecholamines and adrenergic compounds displayed an order of affinity that is typical of an alpha-receptor. Nevertheless, protokylol, a potent beta-adrenoceptor agonist, exhibited a higher affinity than that of adrenaline for alpha-sites. This result might be due to its bulky substituent on the amino group. 2 Further displacement experiments between [3H]-DHEC and four pairs of drugs differently substituted on the amino group (isoprenaline vs Cc-25, orciprenaline vs fenoterol, AH 3474 vs labetalol, pindolol vs hydroxybenzylpindolol) provided evidence that N-alkyl substitution decreased the affinity for alpha-sites (20 micromolar less than KD less than 200 micromolar), whereas an N-aralkyl one increased the affinity (0.17 micromloar less than KD less than 4.6 micromolar). 3 It is concluded that a substitution on the amino group by a bulky, hydrophobic moiety enhances the affinity of drugs for the alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216448      PMCID: PMC1668481          DOI: 10.1111/j.1476-5381.1979.tb17344.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  alpha-Adrenergic receptors in rat parotid cells. I. Correlation of [3H]dihydroergocryptine binding and catecholamine-stimulated potassium efflux.

Authors:  W J Strittmatter; J N Davis; R J Lefkowitz
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

2.  Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine.

Authors:  D A Greenberg; S H Snyder
Journal:  Life Sci       Date:  1977-03-15       Impact factor: 5.037

3.  Transformation of the beta2 adrenoceptor in normal rat liver into a beta1 type in Zajdela hepatoma.

Authors:  M L Lacombe; E Rene; G Guellaen; J Hanoune
Journal:  Nature       Date:  1976-07-01       Impact factor: 49.962

4.  Characterization with [3H] dihydroergocryptine of the alpha-adrenergic receptor of the hepatic plasma membrane. Comparison with the beta-adrenergic receptor in normal and adrenalectomized rats.

Authors:  G Guellaen; M Yates-Aggerbeck; G Vauquelin; D Strosberg; J Hanoune
Journal:  J Biol Chem       Date:  1978-02-25       Impact factor: 5.157

5.  Potentiation of beta-sympathomimetics with alpha-adrenoceptor blocking drugs in guinea pig trachea and human bronchus preparations.

Authors:  O T Nousiainen; I Arnala; M M Airaksinen; K Kokkola
Journal:  Pharmacology       Date:  1977       Impact factor: 2.547

6.  Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.

Authors:  M Aggerbeck; G Guellaen; J Hanoune
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

7.  Catecholamine binding to the beta-adrenergic receptor.

Authors:  R J Lefkowitz; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

Review 8.  A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.

Authors:  R T Brittain; G P Levy
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

9.  Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding.

Authors:  L T Williams; D Mullikin; R J Lefkowitz
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

10.  Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site.

Authors:  G D Aurbach; S A Fedak; C J Woodard; J S Palmer; D Hauser; F Troxler
Journal:  Science       Date:  1974-12-27       Impact factor: 47.728

View more
  3 in total

Review 1.  Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.

Authors:  W H Frishman
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

2.  (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.

Authors:  G Engel; D Hoyer; R Berthold; H Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

3.  Adrenergic regulation of glycogenolysis in rat liver after cholestasis. Modulation of the balance between alpha 1 and beta 2 receptors.

Authors:  M Aggerbeck; N Ferry; E S Zafrani; M C Billon; R Barouki; J Hanoune
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.